Skip to main content
Erschienen in: International Ophthalmology 3/2018

18.05.2017 | Original Paper

Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function

verfasst von: Tomislav Bulum, Martina Tomić, Lea Duvnjak

Erschienen in: International Ophthalmology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Previous studies suggested that total serum bilirubin levels are negatively associated with diabetic retinopathy (DR) and nephropathy in patients with diabetes mellitus. The objective of this study was to explore the relationship between serum total bilirubin levels and prevalence of DR in patients with type 1 diabetes (T1DM) and normal renal function.

Methods

Study included 163 T1DM with normal renal function (urinary albumin excretion rate <30 mg/24 h, estimated glomerular filtration rate (eGFR) >60 ml min−11.73 m−2). Photo-documented retinopathy status was made according to the EURODIAB protocol.

Results

Patients with DR were older (49 vs 42 years, p = 0.001), had higher systolic blood pressure (130 vs 120 mmHg, p = 0.001), triglycerides (0.89 vs 0.77 mmol/L, p = 0.01), and lower serum total bilirubin (12 vs 15 U/L, p = 0.02) and eGFR (100 vs 106 ml min−11.73 m−2, p = 0.03). In multivariate logistic regression analysis, only total serum bilirubin was significantly associated with risk of DR in our subjects (OR 0.88, CI 0.81–0.96, p = 0.006).

Conclusion

These data suggest that serum total bilirubin levels are independently negatively associated with DR in T1DM with normal renal function. Prospective studies are needed to confirm whether lower serum total bilirubin has predictive value for the development of DR in T1DM with normal renal function.
Literatur
2.
Zurück zum Zitat Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed
3.
Zurück zum Zitat Ram M, Singh V, Kumar D et al (2014) Antioxidant potential of bilirubin-accelerated wound healing in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 387:955–961CrossRefPubMed Ram M, Singh V, Kumar D et al (2014) Antioxidant potential of bilirubin-accelerated wound healing in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 387:955–961CrossRefPubMed
4.
Zurück zum Zitat Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820CrossRefPubMed
5.
Zurück zum Zitat Dekker D, Dorresteijn MJ, Pijnenburg M et al (2011) The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 31:458–463CrossRefPubMed Dekker D, Dorresteijn MJ, Pijnenburg M et al (2011) The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 31:458–463CrossRefPubMed
6.
Zurück zum Zitat Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046CrossRefPubMed Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046CrossRefPubMed
7.
Zurück zum Zitat Abbasi A, Deetman PE, Corpeleijn E et al (2015) Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes 64:1459–1469CrossRefPubMed Abbasi A, Deetman PE, Corpeleijn E et al (2015) Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes 64:1459–1469CrossRefPubMed
8.
Zurück zum Zitat Djousse L, Levy D, Cupples LA et al (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200CrossRefPubMed Djousse L, Levy D, Cupples LA et al (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200CrossRefPubMed
9.
Zurück zum Zitat Cheriyath P, Gorrepati VS, Peters I et al (2010) High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res 2:201–206PubMedPubMedCentral Cheriyath P, Gorrepati VS, Peters I et al (2010) High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res 2:201–206PubMedPubMedCentral
10.
Zurück zum Zitat Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T (2007) Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 298:1396–1400CrossRef Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T (2007) Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA 298:1396–1400CrossRef
11.
Zurück zum Zitat Kim ES, Lee SW, Mo EY, Moon SD, Han JH (2015) Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. Endocrine 50:405–412CrossRefPubMed Kim ES, Lee SW, Mo EY, Moon SD, Han JH (2015) Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes. Endocrine 50:405–412CrossRefPubMed
12.
Zurück zum Zitat Fukui M, Tanaka M, Shiraishi E et al (2008) Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 74:1197–1201CrossRefPubMed Fukui M, Tanaka M, Shiraishi E et al (2008) Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int 74:1197–1201CrossRefPubMed
13.
Zurück zum Zitat Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus. J Diabetes Complicat 29:218–221CrossRefPubMed Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus. J Diabetes Complicat 29:218–221CrossRefPubMed
14.
Zurück zum Zitat Najam SS, Sun J, Zhang J et al (2014) Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population. J Diabetes 6:221–227CrossRefPubMed Najam SS, Sun J, Zhang J et al (2014) Serum total bilirubin levels and prevalence of diabetic retinopathy in a Chinese population. J Diabetes 6:221–227CrossRefPubMed
15.
Zurück zum Zitat Nishimura T, Tanaka M, Sekioka R, Itoh H (2015) Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus. J Diabetes Complicat 29:1223–1227CrossRefPubMed Nishimura T, Tanaka M, Sekioka R, Itoh H (2015) Serum bilirubin concentration is associated with eGFR and urinary albumin excretion in patients with type 1 diabetes mellitus. J Diabetes Complicat 29:1223–1227CrossRefPubMed
16.
Zurück zum Zitat Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Low serum total bilirubin concentration in patients with type 1 diabetes mellitus complicated by retinopathy and nephropathy. Diabetol Int 6:300–305CrossRef Sekioka R, Tanaka M, Nishimura T, Itoh H (2015) Low serum total bilirubin concentration in patients with type 1 diabetes mellitus complicated by retinopathy and nephropathy. Diabetol Int 6:300–305CrossRef
17.
Zurück zum Zitat Grunwald JE, Alexander J, Ying GS et al (2012) Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol 130:1136–1144CrossRefPubMedPubMedCentral Grunwald JE, Alexander J, Ying GS et al (2012) Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol 130:1136–1144CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Prašek M, Pavković P, Knotek M (2012) Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 45:1694–1696CrossRefPubMed Vučić Lovrenčić M, Radišić Biljak V, Božičević S, Prašek M, Pavković P, Knotek M (2012) Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria. Clin Biochem 45:1694–1696CrossRefPubMed
20.
Zurück zum Zitat Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437–444CrossRefPubMed Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 38:437–444CrossRefPubMed
21.
Zurück zum Zitat Nakagami T, Toyomura K, Kinoshita T, Morisawa S (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158:189–193CrossRefPubMed Nakagami T, Toyomura K, Kinoshita T, Morisawa S (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158:189–193CrossRefPubMed
22.
Zurück zum Zitat Kumar A, Pant P, Basu S, Rao GR, Khanna HD (2007) Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 53:69–71CrossRefPubMed Kumar A, Pant P, Basu S, Rao GR, Khanna HD (2007) Oxidative stress in neonatal hyperbilirubinemia. J Trop Pediatr 53:69–71CrossRefPubMed
23.
Zurück zum Zitat Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidant of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51:859–862CrossRefPubMed Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidant of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51:859–862CrossRefPubMed
24.
Zurück zum Zitat Mietus-Synder M, Friera A, Glass CK, Pitas RE (1997) Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 17:969–978CrossRef Mietus-Synder M, Friera A, Glass CK, Pitas RE (1997) Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 17:969–978CrossRef
25.
Zurück zum Zitat Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC (2008) Plasma MDA and antioxidant vitamins in diabetic retinopathy. Indian J Clin Biochem 23:158–162CrossRefPubMedPubMedCentral Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC (2008) Plasma MDA and antioxidant vitamins in diabetic retinopathy. Indian J Clin Biochem 23:158–162CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK (2011) Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med 2:107–112CrossRefPubMedPubMedCentral Bhutia Y, Ghosh A, Sherpa ML, Pal R, Mohanta PK (2011) Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. J Nat Sci Biol Med 2:107–112CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859–866CrossRefPubMed Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859–866CrossRefPubMed
28.
Zurück zum Zitat Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D (2000) Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23:234–240CrossRefPubMed Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D (2000) Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23:234–240CrossRefPubMed
29.
Zurück zum Zitat Ishibashi F, Kawasaki A, Kojima R, Taniguchi M, Kosaka A, Uetake H (2014) Association between serum total bilirubin levels and the morphology of corneal nerve fibers in Japanese patients with uncontrolled type 2 diabetes. Diabetes Care 37:e131–e132CrossRefPubMed Ishibashi F, Kawasaki A, Kojima R, Taniguchi M, Kosaka A, Uetake H (2014) Association between serum total bilirubin levels and the morphology of corneal nerve fibers in Japanese patients with uncontrolled type 2 diabetes. Diabetes Care 37:e131–e132CrossRefPubMed
31.
Zurück zum Zitat Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C (2011) The relationship between diabetic retinopathy and serum levels of ischemia-induced albumin and malondialdehyde. Retina 31:602–608CrossRefPubMed Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C (2011) The relationship between diabetic retinopathy and serum levels of ischemia-induced albumin and malondialdehyde. Retina 31:602–608CrossRefPubMed
32.
Zurück zum Zitat Dave A, Kalra P, Rakshitha Gowda BH, Krishnaswamy M (2015) Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus. Indian J Endocrinol Metab 19:373–377CrossRefPubMedPubMedCentral Dave A, Kalra P, Rakshitha Gowda BH, Krishnaswamy M (2015) Association of bilirubin and malondialdehyde levels with retinopathy in type 2 diabetes mellitus. Indian J Endocrinol Metab 19:373–377CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zhu B, Wu X, Ning K, Jiang F, Zhang L (2016) The negative relationship between bilirubin level and diabetic retinopathy: a meta-analysis. PLoS ONE 11:e0161649CrossRefPubMedPubMedCentral Zhu B, Wu X, Ning K, Jiang F, Zhang L (2016) The negative relationship between bilirubin level and diabetic retinopathy: a meta-analysis. PLoS ONE 11:e0161649CrossRefPubMedPubMedCentral
Metadaten
Titel
Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function
verfasst von
Tomislav Bulum
Martina Tomić
Lea Duvnjak
Publikationsdatum
18.05.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 3/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0565-8

Weitere Artikel der Ausgabe 3/2018

International Ophthalmology 3/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.